Skip to contentC
ClearPoint Neuro, Inc.
C
CLPTClearPoint Neuro, Inc. Q3 2023 · 10-Q
Revenue$5.76M$5.76M+12.0% vs Q3 2022 Net Income-$4.81M-$4.81MN/M vs Q3 2022 EPS Diluted-$0.20-$0.20N/M vs Q3 2022 Gross Profit$3,273,000−11.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ClearPoint Neuro, Inc. · CIK 1285550 · Engraved from SEC EDGAR
Operating Cash Flowderived-$1,796,000N/M Free Cash Flowderived-$2,031,000N/M Margins · derivedGross margin56.8%−14.7 pt vs Q3 2022
Operating margin-85.0%−11.2 pt vs Q3 2022
Net margin-83.5%−9.9 pt vs Q3 2022
ended Sep 30, 2023 · filed Nov 9, 2023 · 40 d after period end